Council for europe portal
Language : en Search
Choose language

European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH)

Governance  

The quality of medicine and the way a medicine is prescribeddelivered or simply taken by the patients are key factors that can have a direct impact on the efficiency of a treatment and can put the patients’ health at risk. Often the benefits of medications cannot be realised in patients and even worse considerable mortality and morbidity are related to inappropriate and unsafe use of medicines (e.g. prescribing errors, dispensing errors, non-adherence with treatment regimen).

To minimise risks for patients’ health and ensure the same access to treatment for all, the EDQM is in charge of harmonising the pharmaceutical practices throughout Europe. This activity covers a wide range of subjects relevant to pharmacy practice, including patients’ access to good quality medicines, promotion of patient-centred care and effective use of medicines, and quality and safety of pharmacy preparations. Pharmaceutical practices evolve and there is a need for harmonisation and sharing of knowledge and expertise across Europe.

Medicine box for not forget to take medications

Organisation and subordinate bodies

In the field of health, the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH) supports authorities in times of increasing social gaps and resource constraints to make the medication process safer, more responsible and accessible to all who need it.

The CD-P-PH oversees the drafting process of legal instruments (e.g. resolutions), policies and guidance documents and exercises general oversight over the activities of the European Pharmacopoeia Commission.

The CD-P-PH supports the European Pharmacopoeia Commission in the elaboration of the European Paediatric Formulary, i.e. an initiative to make available a formulary for extemporaneous formulations for paediatric medicines that is a compilation of monographs for their preparation based on national or regional information. The aim of this initiative is to give pharmacists and clinicians access to formulations of appropriate quality, allowing preparation of a medicinal product when no licensed alternative is available on the market. The project was launched in 2013 and is currently ongoing.

The CD-P-PH consists of senior officials in ministries and medicines agencies responsible for health policies and accomplishes its tasks with the support of three subordinate committees of experts (see below).

 

Committee of Experts on the Classification of Medicines
as Regards their Supply

not visible

(CD-P-PH/PHO)

Committee of Experts on the Classification of Medicines as Regards their Supply

 

 

Committee of Experts on Quality and Safety Standards in
Pharmaceutical Practices and Pharmaceutical Care 

(CD-P-PH/PC)

Committee of Experts on Quality and Safety Standards in Pharmaceutical Practices and Pharmaceutical Care 

 

Committee of Experts on Minimising the Public Health Risks Posed
by Falsification of Medical Products and Related Crimes

(CD-P-PH/CMED)

 

 

European Paediatric Formulary Project
(joint project CD-P-PH and European Pharmacopoeia Commission)

not visible

 

Communication with partners and stakeholders

Interactions take place on a regular basis with international organisations and professional bodies active in the field of public health and pharmacy practice (e.g. World Health Organization (WHO) and the European Association of Hospital Pharmacists (EAHP)) in order to align efforts aimed at ensuring safe and appropriate use of medicines in Europe.

twitter facebook googleplus pinterest linkedin email